Loading…
  • Therapie der Zukunft: we fight your cancer

PublikationenCN刊物

PSMA therapy under more restrictive regimen of 4-week intervals

How oft is the Lu-PSMA treatment conducted? The usual c…

Ga-68 demonstrates superiority to F-18 in digital PSMA-PET/CT scans for staging prostate cancer

Fluorine-18 is a commonly used isotope utilized for con…

PSMA therapy improves health-related quality of life in patients with prostate cancer

On Friday, 17 September 2021, Novartis announced furthe…

NCCN Guidelines add PSMA-PET imaging for prostate cancer

National Comprehensive Cancer Network, an alliance of c…

0 条评论

Frontiers in Urology

Frontiers in Urology

0 条评论

Working group headed by Prof. Markus Hartenbach was able to demonstrate the outstanding diagnostic value of PSMA PET / MRI in biopsy-proven prostate cancer

Working group headed by Prof. Markus Hartenbach was abl…

0 条评论

Working group under Prof. Hartenbach MD demonstrates superiority of PSMA PET in diagnosing recurring prostate cancer

The working group headed by Prof. Markus Hartenbach MD …

0 条评论

Markus Hartenbach wins Oncology Council’s Young Investigator Award

Markus Hartenbach wins Oncology Council’s Young Investi…

0 条评论

NET Patient Education Conference of NET Research Foundation on Theranostics (PRRT)

Video: Nuclear imaging 68Ga-DOTATATE and PRRT 177Lu-DOT…

New phase III 177Lu-PSMA-617 trial in mCRPC patients at…

0 条评论

New phase III 177Lu-PSMA-617 trial in mCRPC patients wh…

0 条评论

ASCO 2021: Phase III Study of Lutetium-177-PSMA-617 in …

0 条评论

The New England Journal of Medicine: “Lutetium-17…

0 条评论

Novartis announces positive result of phase III study w…

0 条评论

PSMA-治疗

[177Lu]-PSMA-617 radionuclide treatment in patients wit…

0 条评论

二氯化镭-223 治疗(Xofigo®)

Alpha emitter radium-223 and survival in metastatic pro…

0 条评论

PSMA 成像

68Ga-PSMA 11 ligand PET imaging in patients with bioche…

0 条评论

神经内分泌肿瘤(PRRT)

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocri…

0 条评论